Janine C. Deddens

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

miR-132/212 Impairs Cardiomyocytes Contractility in the Failing Heart by Suppressing SERCA2a.

miR-132/212 Impairs Cardiomyocytes Contractility in the Failing Heart by Suppressing SERCA2a.

Journal: Frontiers in cardiovascular medicine

Published: August 07, 2020

Loss of miR-132/212 Has No Long-Term Beneficial Effect on Cardiac Function After Permanent Coronary Occlusion in Mice.

Loss of miR-132/212 Has No Long-Term Beneficial Effect on Cardiac Function After Permanent Coronary Occlusion in Mice.

Journal: Frontiers in physiology

Published: March 21, 2020

Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis.

Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis.

Journal: Frontiers in cardiovascular medicine

Published: September 22, 2018

Cardiac Progenitor Cell-Derived Extracellular Vesicles Reduce Infarct Size and Associate with Increased Cardiovascular Cell Proliferation.

Cardiac Progenitor Cell-Derived Extracellular Vesicles Reduce Infarct Size and Associate with Increased Cardiovascular Cell Proliferation.

Journal: Journal of cardiovascular translational research

Published: August 29, 2018

Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles.

Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles.

Journal: Heliyon

Published: December 28, 2017

Variation within Variation: Comparison of 24-h Rhythm in Rodent Infarct Size between Ischemia Reperfusion and Permanent Ligation.

Variation within Variation: Comparison of 24-h Rhythm in Rodent Infarct Size between Ischemia Reperfusion and Permanent Ligation.

Journal: International journal of molecular sciences

Published: July 04, 2017

Cardiac-released extracellular vesicles can activate endothelial cells.

Cardiac-released extracellular vesicles can activate endothelial cells.

Journal: Annals of translational medicine

Published: March 03, 2017

Engineered 3D Cardiac Fibrotic Tissue to Study Fibrotic Remodeling.

Engineered 3D Cardiac Fibrotic Tissue to Study Fibrotic Remodeling.

Journal: Advanced healthcare materials

Published: December 14, 2016

Targeting chronic cardiac remodeling with cardiac progenitor cells in a murine model of ischemia/reperfusion injury.

Targeting chronic cardiac remodeling with cardiac progenitor cells in a murine model of ischemia/reperfusion injury.

Journal: PloS one

Published: November 26, 2016

Modeling the Human Scarred Heart In Vitro: Toward New Tissue Engineered Models.

Modeling the Human Scarred Heart In Vitro: Toward New Tissue Engineered Models.

Journal: Advanced healthcare materials

Published: May 29, 2016

Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury.

Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury.

Journal: Journal of cardiovascular translational research

Published: March 30, 2016

Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN.

Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN.

Journal: Advanced healthcare materials

Published: March 23, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026